Nanobiotix S.A. Discloses Managerial Transactions
Ticker: NBTX · Form: 6-K · Filed: Apr 10, 2025 · CIK: 1760854
Sentiment: neutral
Topics: insider-trading, disclosure, management
TL;DR
Nanobiotix filed manager trades from Dec 2024 on April 10, 2025.
AI Summary
On April 10, 2025, Nanobiotix S.A. disclosed transactions by individuals in managerial positions. The filing, a Form 6-K, was made for the month of December 2024, indicating a reporting delay. The company, headquartered in Paris, France, operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides transparency into the trading activities of Nanobiotix's key personnel, which can offer insights into their confidence in the company's future performance.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of managerial transactions and does not contain new material financial or operational information.
Key Players & Entities
- Nanobiotix S.A. (company) — Registrant
- 001-39777 (company) — Commission File Number
- April 10, 2025 (date) — Filing Date
- December 2024 (date) — Reporting Period
- 60 rue de Wattignies 75012 Paris, France (address) — Principal Executive Offices
FAQ
What type of transactions are being disclosed by Nanobiotix S.A.?
Nanobiotix S.A. is disclosing transactions by persons discharging managerial responsibilities.
What is the form type and filing date of this report?
The form type is 6-K, and it was filed on April 10, 2025.
For which period is this report intended to cover disclosures?
This report is for the month of December 2024.
What is Nanobiotix S.A.'s commission file number?
Nanobiotix S.A.'s commission file number is 001-39777.
Where are Nanobiotix S.A.'s principal executive offices located?
Nanobiotix S.A.'s principal executive offices are located at 60 rue de Wattignies, 75012 Paris, France.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 10, 2025 regarding Nanobiotix S.A. (NBTX).